15 results
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
Leadership Structure and Role in Risk Oversight
Evaluations of the Board of Directors
Stockholder Communications
Code of Business Conduct and Ethics
Anti … transactions between us and a related person for which review or oversight is required by applicable law or that are required to be disclosed in our
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance … or similar programs in other countries or jurisdictions, integrity oversight and reporting obligations to resolve allegations of non-compliance, disgorgement
424B4
qh115g
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
86hy2 d4h
5 Dec 22
IPO registration (amended)
8:16am
S-1
jga07p r14h96
18 Nov 22
IPO registration
5:06pm
S-1
EX-3.1
sfjp dam5ck
18 Nov 22
IPO registration
5:06pm
DRS/A
pqmch4
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
EX-3
prim4hxhpycq
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
mi58q
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
2iu g8ejpx6ydjfv0op
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next